Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.45 TWD
−639.89 M TWD
1.79 B TWD
347.20 M
About ADIMMUNE CORPORATION
Sector
CEO
Chung Cheng Liu
Headquarters
Taichung
Website
Founded
1965
ISIN
TW0004142005
FIGI
BBG001636XY8
Adimmune Corp. engages in the manufacturing and sales of influenza vaccine. Its products include Trivalent Influenza vaccine, Tetravalent Influenza vaccine, Influenza A (H1N1) Virus Monovalent Vaccine, Japanese Encephalitis Vaccine (JEV), and Tetanus toxoid, and purified Tuberculin. Its business scope includes research and development, processing, manufacturing, and trading of serum, vaccines, test reagents, biological agents and their bacterial liquids, and raw materials. The company was founded on December 22, 1965 and is headquartered in Taichung, Taiwan.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 4142 is 19.20 TWD — it has decreased by −0.52% in the past 24 hours. Watch ADIMMUNE CORPORATION stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange ADIMMUNE CORPORATION stocks are traded under the ticker 4142.
4142 stock has fallen by −6.80% compared to the previous week, the month change is a −14.09% fall, over the last year ADIMMUNE CORPORATION has showed a −42.43% decrease.
We've gathered analysts' opinions on ADIMMUNE CORPORATION future price: according to them, 4142 price has a max estimate of 23.00 TWD and a min estimate of 23.00 TWD. Watch 4142 chart and read a more detailed ADIMMUNE CORPORATION stock forecast: see what analysts think of ADIMMUNE CORPORATION and suggest that you do with its stocks.
4142 reached its all-time high on Jul 2, 2020 with the price of 79.80 TWD, and its all-time low was 13.65 TWD and was reached on Aug 25, 2015. View more price dynamics on 4142 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
4142 stock is 2.09% volatile and has beta coefficient of 0.35. Track ADIMMUNE CORPORATION stock price on the chart and check out the list of the most volatile stocks — is ADIMMUNE CORPORATION there?
Today ADIMMUNE CORPORATION has the market capitalization of 8.09 B, it has decreased by −7.85% over the last week.
Yes, you can track ADIMMUNE CORPORATION financials in yearly and quarterly reports right on TradingView.
ADIMMUNE CORPORATION is going to release the next earnings report on Mar 12, 2025. Keep track of upcoming events with our Earnings Calendar.
4142 earnings for the last quarter are 0.61 TWD per share, whereas the estimation was 3.24 TWD resulting in a −81.17% surprise. The estimated earnings for the next quarter are 0.21 TWD per share. See more details about ADIMMUNE CORPORATION earnings.
ADIMMUNE CORPORATION revenue for the last quarter amounts to 888.00 M TWD, despite the estimated figure of 1.24 B TWD. In the next quarter, revenue is expected to reach 680.00 M TWD.
4142 net income for the last quarter is 263.30 M TWD, while the quarter before that showed −273.78 M TWD of net income which accounts for 196.17% change. Track more ADIMMUNE CORPORATION financial stats to get the full picture.
As of Dec 21, 2024, the company has 527.00 employees. See our rating of the largest employees — is ADIMMUNE CORPORATION on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ADIMMUNE CORPORATION EBITDA is −382.65 M TWD, and current EBITDA margin is −27.93%. See more stats in ADIMMUNE CORPORATION financial statements.
Like other stocks, 4142 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ADIMMUNE CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ADIMMUNE CORPORATION technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ADIMMUNE CORPORATION stock shows the strong sell signal. See more of ADIMMUNE CORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.